𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adrenal Suppression with Dry Powder Formulations of Fluticasone Propionate and Mometasone Furoate

✍ Scribed by Fardon, Tom C.; Lee, Daniel K. C.; Haggart, Kay; McFarlane, Lesley C.; Lipworth, Brian J.


Book ID
120010825
Publisher
American Thoracic Society
Year
2004
Tongue
English
Weight
94 KB
Volume
170
Category
Article
ISSN
1073-449X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Dry powder formulations for inhalation o
✍ Darragh Murnane; Gary P. Martin; Christopher Marriott πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 307 KB

Direct crystallization of active pharmaceutical ingredient (API) particles in the inhalable size range of 1-6 microm may overcome surface energization resulting from micronization. The aerosolization of fluticasone propionate (FP) and salmeterol xinafoate (SX) microcrystals produced by aqueous cryst